کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2564804 1561038 2015 7 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Adverse performance effects of acute lorazepam administration in elderly long-term users: Pharmacokinetic and clinical predictors
ترجمه فارسی عنوان
اثرات نامطلوب تجویز حاد لورازپام در سالمندان مصرف کننده درازمدت: عوامل پیش بینی کننده فارماکوکینتیک و بالینی
کلمات کلیدی
سالخورده، سمیت شناختی، لورازپام، از دست دادن حافظه، کاهش روانشناختی، بنزودیازپین ها
موضوعات مرتبط
علوم زیستی و بیوفناوری علم عصب شناسی روانپزشکی بیولوژیکی
چکیده انگلیسی


• Administration of lorazepam in long term elderly users produced poor memory.
• Prescribed doses also produced slower psychomotor performance.
• No significant effects on self-ratings of mood, sedation or anxiety were detected.
• These findings raise concerns about the long-term use of lorazepam in the elderly.

BackgroundThe benzodiazepine lorazepam is widely utilized in the treatment of elderly individuals with anxiety disorders and related conditions. Negative effects of acute lorazepam administration on cognitive performance, especially memory, have been reported in both previously untreated elderly and in individuals who have received short term (up to three weeks) treatment with therapeutic doses. However, it remains unclear if these adverse cognitive effects also persist after long-term use, which is frequently found in clinical practice.MethodsCognitively intact elderly individuals (n = 37) on long-term (at least three months) daily treatment with lorazepam were studied using a double-blind placebo-controlled cross-over study design. Subjects were administered their highest daily unit dose of lorazepam (0.25–3.00 mg) or placebo on different days, approximately 1 week apart in a random order, and were assessed on memory, psychomotor speed, and subjective mood states.ResultsSubjects had significantly poorer recall and slowed psychomotor performance following acute lorazepam administration. There were no significant effects on self-ratings of mood, sedation, or anxiety in the whole group, but secondary analyses suggested a differential response in subjects with Generalized Anxiety Disorder.ConclusionsThe reduced recall and psychomotor slowing that we observed, along with an absence of significant therapeutic benefits, following acute lorazepam administration in elderly long-term users reinforces the importance of cognitive toxicity as a clinical factor in benzodiazepine use, especially in this population.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Progress in Neuro-Psychopharmacology and Biological Psychiatry - Volume 56, 2 January 2015, Pages 129–135
نویسندگان
, , , , , , ,